<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BCL-2 is a membrane protein known to be an <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inhibitor </plain></SENT>
<SENT sid="1" pm="."><plain>It is the product of the bcl-2 gene located on chromosome 18 </plain></SENT>
<SENT sid="2" pm="."><plain>Several different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> show BCL-2 over-expression as result of a translocation or independently from it </plain></SENT>
<SENT sid="3" pm="."><plain>More than 85% of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and a smaller number of diffuse large cell B <z:hpo ids='HP_0002665'>lymphomas</z:hpo> contain t(14;18) (q32;q21) </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study was to investigate the immunohistochemical expression of the BCL-2 protein and to ascertain, by means of traditional PCR (Polimerase Chain Reaction), its possible dependence from t(14;18) (q32;q21) in 9 primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Six cases (67%) shoved immunohistochemical BCL-2 over-expression and 3 cases (33%) had t(14;18) </plain></SENT>
<SENT sid="6" pm="."><plain>Precisely: 2 cases (22%) had immunohistochemical BCL-2 over-expression and t(14;18) (q32;q21); 4 cases (44%) had BCL-2 over-expression without translocation; 1 case (11%) did not show diffuse BCL-2 over-expression in presence of the traslocation; the remaining 2 cases (22%) did not demonstrate BCL-2 over-expression or t(14;18) (q32;q21) </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, our results indicate primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphomas</z:hpo> frequently show BCL-2 over-expression that in some case may be related to t(14;18) (q32;q21) </plain></SENT>
<SENT sid="8" pm="."><plain>Nevertheless, t(14;18) (q32;q21), as evaluated by traditional PCR, may not correspond to diffuse immunohistochemical BCL-2 positivity </plain></SENT>
</text></document>